Myriad Genetics Market Cap

Myriad Genetics has a market cap or net worth of $565.74 million as of July 2, 2026. Its market cap has increased by 23.26% in one year.

Market Cap

565.74M

Enterprise Value

652.84M

1-Year Change

23.26%

Ranking

#3035

Market Cap Chart

Since December 1, 1998, Myriad Genetics's market cap has increased from $102.30M to $565.74M, an increase of 453.03%. That is a compound annual growth rate of 6.39%.

Market Cap History

Date	Market Cap	% Change
Jul 2, 2026	565.70M	-1.33%
Dec 31, 2025	573.30M	-54.07%
Dec 31, 2024	1.25B	-20.67%
Dec 29, 2023	1.57B	33.81%
Dec 30, 2022	1.18B	-46.65%
Dec 31, 2021	2.20B	48.19%
Dec 31, 2020	1.49B	-26.57%
Dec 31, 2019	2.03B	-6.80%
Dec 31, 2018	2.17B	-8.61%
Dec 29, 2017	2.38B	108.51%
Dec 30, 2016	1.14B	-62.13%
Dec 31, 2015	3.01B	21.14%
Dec 31, 2014	2.49B	58.51%
Dec 31, 2013	1.57B	-29.30%
Dec 31, 2012	2.22B	25.03%
Dec 30, 2011	1.77B	-15.91%
Dec 31, 2010	2.11B	-15.93%
Dec 31, 2009	2.51B	-18.54%
Dec 31, 2008	3.08B	50.95%
Dec 31, 2007	2.04B	64.00%
Dec 29, 2006	1.24B	93.29%
Dec 30, 2005	643.90M	-6.71%
Dec 31, 2004	690.20M	98.11%
Dec 31, 2003	348.40M	-0.17%
Dec 31, 2002	349.00M	-71.84%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
GRAIL	2.97B
GeneDx Holdings	2.00B
NeoGenomics	1.97B
CareDx	1.51B
Personalis	1.43B
OPKO Health	1.15B
Castle Biosciences	731.26M
Fulgent Genetics	592.15M

Market Cap Rankings